OMNICELL, INC.
Price data unavailable
Track OMCL in your trading journalAbout OMNICELL, INC.
OMNICELL, INC. (OMCL) is a publicly traded US company. Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
The company reports trailing twelve-month revenue of $228.81M and net income of $11.36M.
Key metrics include a return on equity of 0.9%, a debt-to-equity ratio of 0.59.
Investors tracking OMCL can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.
Fundamentals
| Revenue (TTM) | $228.81M |
| Net Income (TTM) | $11.36M |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | 0.90% |
| Debt-to-Equity | 0.59 |
| Dividend per Share | — |
Recent News
Want real-time analysis on OMCL?
Track it free in your trading journal. Log trades, tag setups, and review your edge.